GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellCura ASA (FRA:C6L) » Definitions » Equity-to-Asset

CellCura ASA (FRA:C6L) Equity-to-Asset : -1.16 (As of Jun. 2014)


View and export this data going back to . Start your Free Trial

What is CellCura ASA Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. CellCura ASA's Total Stockholders Equity for the quarter that ended in Jun. 2014 was €-2.21 Mil. CellCura ASA's Total Assets for the quarter that ended in Jun. 2014 was €1.91 Mil. Therefore, CellCura ASA's Equity to Asset Ratio for the quarter that ended in Jun. 2014 was -1.16.

The historical rank and industry rank for CellCura ASA's Equity-to-Asset or its related term are showing as below:

FRA:C6L's Equity-to-Asset is not ranked *
in the Biotechnology industry.
Industry Median: 0.67
* Ranked among companies with meaningful Equity-to-Asset only.

CellCura ASA Equity-to-Asset Historical Data

The historical data trend for CellCura ASA's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellCura ASA Equity-to-Asset Chart

CellCura ASA Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Equity-to-Asset
Get a 7-Day Free Trial -0.06 0.78 0.47 -0.22 -0.49

CellCura ASA Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.34 -0.20 -0.57 -0.67 -1.16

Competitive Comparison of CellCura ASA's Equity-to-Asset

For the Biotechnology subindustry, CellCura ASA's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellCura ASA's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellCura ASA's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where CellCura ASA's Equity-to-Asset falls into.



CellCura ASA Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

CellCura ASA's Equity to Asset Ratio for the fiscal year that ended in Dec. 2013 is calculated as

Equity to Asset (A: Dec. 2013 )=Total Stockholders Equity/Total Assets
=-1.18/2.392
=-0.49

CellCura ASA's Equity to Asset Ratio for the quarter that ended in Jun. 2014 is calculated as

Equity to Asset (Q: Jun. 2014 )=Total Stockholders Equity/Total Assets
=-2.206/1.905
=-1.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellCura ASA  (FRA:C6L) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


CellCura ASA Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of CellCura ASA's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


CellCura ASA (FRA:C6L) Business Description

Traded in Other Exchanges
N/A
Address
Unionsgata 18, Skien, NOR, 3732
CellCura ASA is engaged in the development of novel equipment & products for use in Assisted Reproductive Technology & Stem Cell Research globally. The company also offers software solutions used in ART lab for securing the storage & management of data.

CellCura ASA (FRA:C6L) Headlines

No Headlines